Drug Type Fusion protein |
Synonyms YH 25724, YH25724 |
Target |
Mechanism FGF21R agonists, GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Phase 1 | KR | - | |
Fibrosis, Liver | Preclinical | KR | 13 Apr 2019 | |
Diabetes Mellitus, Type 2 | Preclinical | KR | 14 Sep 2016 | |
Liver Cirrhosis | Preclinical | KR | - |